Connection

Robert Haile to United States

This is a "connection" page, showing publications Robert Haile has written about United States.
Connection Strength

0.666
  1. "Cancer Center Catchment Area Assessment"-Letter. Cancer Epidemiol Biomarkers Prev. 2022 07 01; 31(7):1507.
    View in: PubMed
    Score: 0.084
  2. Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans. Cancer Prev Res (Phila). 2020 09; 13(9):773-782.
    View in: PubMed
    Score: 0.073
  3. A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila). 2012 Feb; 5(2):150-63.
    View in: PubMed
    Score: 0.041
  4. A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1812-21.
    View in: PubMed
    Score: 0.037
  5. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1863-70.
    View in: PubMed
    Score: 0.028
  6. Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). Int J Epidemiol. 2018 04 01; 47(2):387-388i.
    View in: PubMed
    Score: 0.016
  7. Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014. JAMA Oncol. 2018 Mar 01; 4(3):317-323.
    View in: PubMed
    Score: 0.016
  8. Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations. PLoS One. 2018; 13(2):e0192223.
    View in: PubMed
    Score: 0.015
  9. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol. 2018 01 01; 36(1):25-33.
    View in: PubMed
    Score: 0.015
  10. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study. J Natl Cancer Inst. 2017 10 01; 109(10).
    View in: PubMed
    Score: 0.015
  11. Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers. Cancer. 2017 Jul 01; 123(13):2516-2523.
    View in: PubMed
    Score: 0.014
  12. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer. 2016 10 01; 139(7):1557-63.
    View in: PubMed
    Score: 0.014
  13. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. Int J Epidemiol. 2016 06; 45(3):940-53.
    View in: PubMed
    Score: 0.014
  14. Determining the familial risk distribution of colorectal cancer: a data mining approach. Fam Cancer. 2016 Apr; 15(2):241-51.
    View in: PubMed
    Score: 0.014
  15. Lynch syndrome and cervical cancer. Int J Cancer. 2015 Dec 01; 137(11):2757-61.
    View in: PubMed
    Score: 0.013
  16. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. J Natl Cancer Inst. 2015 Sep; 107(9).
    View in: PubMed
    Score: 0.013
  17. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol. 2015 May; 1(2):214-21.
    View in: PubMed
    Score: 0.013
  18. Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2250-65.
    View in: PubMed
    Score: 0.012
  19. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nat Commun. 2014 Aug 08; 5:4613.
    View in: PubMed
    Score: 0.012
  20. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1547-56.
    View in: PubMed
    Score: 0.011
  21. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes Control. 2013 Aug; 24(8):1605-14.
    View in: PubMed
    Score: 0.011
  22. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol. 2013 Jun; 20(6):1829-36.
    View in: PubMed
    Score: 0.011
  23. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013 Feb 01; 31(4):433-9.
    View in: PubMed
    Score: 0.011
  24. Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population. Cancer Epidemiol Biomarkers Prev. 2012 Dec; 21(12):2261-7.
    View in: PubMed
    Score: 0.011
  25. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst. 2012 Sep 19; 104(18):1363-72.
    View in: PubMed
    Score: 0.011
  26. The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials. 2012 Mar; 33(2):426-35.
    View in: PubMed
    Score: 0.010
  27. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer. 2011 Nov 01; 129(9):2256-62.
    View in: PubMed
    Score: 0.010
  28. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer. 2010 Dec 01; 127(11):2678-84.
    View in: PubMed
    Score: 0.009
  29. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 May 10; 28(14):2404-10.
    View in: PubMed
    Score: 0.009
  30. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8.
    View in: PubMed
    Score: 0.009
  31. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010 Feb 03; 102(3):193-201.
    View in: PubMed
    Score: 0.009
  32. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009 Mar 18; 101(6):432-5.
    View in: PubMed
    Score: 0.008
  33. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol. 2009 Apr 15; 169(8):962-8.
    View in: PubMed
    Score: 0.008
  34. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009 Apr; 136(4):1251-60.
    View in: PubMed
    Score: 0.008
  35. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res. 2008 Aug 15; 68(16):6486-91.
    View in: PubMed
    Score: 0.008
  36. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1021-30.
    View in: PubMed
    Score: 0.008
  37. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. J Clin Oncol. 2008 Mar 20; 26(9):1411-8.
    View in: PubMed
    Score: 0.008
  38. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2331-43.
    View in: PubMed
    Score: 0.008
  39. Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):906-11.
    View in: PubMed
    Score: 0.007
  40. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes Control. 2006 Dec; 17(10):1299-304.
    View in: PubMed
    Score: 0.007
  41. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat. 2003 May; 21(5):542-50.
    View in: PubMed
    Score: 0.006
  42. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):622-9.
    View in: PubMed
    Score: 0.005
  43. Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):660-3.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.